Covid19 services

ERINHA offers access to a large range of high containment in-vitro and in-vivo capacities to facilitate a wide variety of studies on SARS-CoV-2/COVID-19.

In vitro research capacity includes but is not limited to
- standard virologic assays
- high‑throughput SARS-CoV-2 antiviral/therapeutic screening assays
- diagnostic development and testing capacity
- virus propagation and quantification
- development of new in vitro assays / methods in accordance with the User’s needs
In vivo research capacity includes but is not limited to:
- Hamster disease model
- Standard in vivo virologic and immunological assays
- Pre-clinical vaccines and therapeutics testing
- Development of new animal models / in vivo methods in accordance with the User’s needs
Additionally, ERINHA provides support for:
- Coordination of pre-clinical research activities
- Project management
- Research protocols and experimental design

This video presents how 9 of the European Life Science Research Infrastructures can be used to advance research on coronavirus and other diseases.

Members

Access our Services

Covid19 services

Members

Our adress

Extra links

Newsletters